Henry, Keith <br/><br/>
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Jun 2006 
 - 140-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-4135 
<br/><br/><label>Standard No.: </label>10.1097/01.qai.0000225319.59652.1e  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>CD4 Lymphocyte Count<br/>Drug Administration Schedule<br/>Drug Resistance, Viral--genetics<br/>Female<br/>HIV Infections--drug therapy<br/>Humans<br/>Interleukin-2--administration & dosage<br/>Male<br/>Pilot Projects<br/>RNA, Viral--blood<br/>Time Factors<br/>Viremia